0001185185-21-000169.txt : 20210209
0001185185-21-000169.hdr.sgml : 20210209
20210209211544
ACCESSION NUMBER: 0001185185-21-000169
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210205
FILED AS OF DATE: 20210209
DATE AS OF CHANGE: 20210209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ODONNELL JEFFREY F
CENTRAL INDEX KEY: 0001226425
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38659
FILM NUMBER: 21608857
MAIL ADDRESS:
STREET 1: 126 ROSSMORE DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioSig Technologies, Inc.
CENTRAL INDEX KEY: 0001530766
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 264333375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 54 WILTON ROAD, 2ND FLOOR
CITY: WESTPORT
STATE: CT
ZIP: 06880
BUSINESS PHONE: (203) 409-5444
MAIL ADDRESS:
STREET 1: 54 WILTON ROAD, 2ND FLOOR
CITY: WESTPORT
STATE: CT
ZIP: 06880
4
1
ownership.xml
X0306
4
2021-02-05
0
0001530766
BioSig Technologies, Inc.
BSGM
0001226425
ODONNELL JEFFREY F
C/O BIOSIG TECHNOLOGIES, INC.
54 WILTON ROAD, 2ND FLOOR
WESTPORT
CT
06880
1
0
0
0
Common Stock
2021-02-05
4
S
0
62238
5.0013
D
194391
D
Common Stock
2021-02-08
4
S
0
42762
5.1237
D
151629
D
Represents the weighted average price of shares sold in multiple transactions at prices ranging from $5.00 to $5.04, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Represents the weighted average price of shares sold in multiple transactions at prices ranging from $5.01 to $5.21, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
/s/ Kenneth L. Londoner, attorney-in-fact
2021-02-09